SCHEMBL21821722

SCHEMBL21821722

CN(C)C=C1C(=O)CC(c2ccc(C(F)(F)F)cc2)CC1=O

nearest known ligand 0.71

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
MAP1LC3B Q9GZQ8 7/20 0.71
HTR2C P28335 4/20 0.41
MEN1 O00255 1/20 0.37
KMT2A Q03164 1/20 0.37
HTR2A P28223 2/20 0.36
HTR2B P41595 2/20 0.36
HRH3 Q9Y5N1 2/20 0.36
ALDH1A1 P00352 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
CYP3A4 P08684 1/20 0.34
CYP2D6 P10635 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21822037 0.83 MAP1LC3B (0.63) MAP1LC3BHTR2CHTR2AHTR2BHRH3
SCHEMBL29581971 0.83 MAP1LC3B (0.63) MAP1LC3BHTR2CHTR2AHTR2BHRH3
SCHEMBL1780581 0.83 MAP1LC3B (1.00) MAP1LC3BMEN1KMT2AALDH1A1L3MBTL1
SCHEMBL1779869 0.81 MAP1LC3B (1.00) MAP1LC3BMEN1KMT2AALDH1A1L3MBTL1
SCHEMBL1781754 0.80 MAP1LC3B (1.00) MAP1LC3BMEN1KMT2AALDH1A1L3MBTL1
SCHEMBL21821964 0.80 MAP1LC3B (0.71) MAP1LC3BMEN1KMT2AALDH1A1L3MBTL1
SCHEMBL21821985 0.80 MAP1LC3B (0.74) MAP1LC3BMEN1KMT2AALDH1A1L3MBTL1
SCHEMBL21822015 0.80 MAP1LC3B (0.44) MAP1LC3BHTR2CMEN1KMT2A
SCHEMBL1780317 0.80 MAP1LC3B (1.00) MAP1LC3BMEN1KMT2AALDH1A1
SCHEMBL21774003 0.78 MAP1LC3B (0.70) MAP1LC3BMEN1KMT2AALDH1A1L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3632903-B1 COMPOUND USED AS AUTOPHAGY REGULATOR, AND PREPARATION METHOD THEREFOR AND USES THEREOF WIGEN BIOMEDICINE TECH SHANGHAI CO LTD (CN) 2023-10-11 EP disclosed
EP-3632903-B1 COMPOUND USED AS AUTOPHAGY REGULATOR, AND PREPARATION METHOD THEREFOR AND USES THEREOF WIGEN BIOMEDICINE TECH SHANGHAI CO LTD (CN) 2023-10-11 EP disclosed
US-11319303-B2 Compound used as autophagy regulator, and preparation method therefor and uses thereof Wigen Biomedicine Technology (shanghai) Co., Ltd. (CN) 2022-05-03 US disclosed
US-11319303-B2 Compound used as autophagy regulator, and preparation method therefor and uses thereof Wigen Biomedicine Technology (shanghai) Co., Ltd. (CN) 2022-05-03 US disclosed
US-20200190066-A1 COMPOUND USED AS AUTOPHAGY REGULATOR, AND PREPARATION METHOD THEREFOR AND USES THEREOF Wigen Biomedicine Technology (shanghai) Co., Ltd. (CN) 2020-06-18 US disclosed
US-20200190066-A1 COMPOUND USED AS AUTOPHAGY REGULATOR, AND PREPARATION METHOD THEREFOR AND USES THEREOF Wigen Biomedicine Technology (shanghai) Co., Ltd. (CN) 2020-06-18 US disclosed
EP-3632903-A1 COMPOUND USED AS AUTOPHAGY REGULATOR, AND PREPARATION METHOD THEREFOR AND USES THEREOF Wigen Biomedicine Technology (Shanghai) Co., Ltd. (CN) 2020-04-08 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11319303-B2 Compound used as autophagy regulator, and preparation method therefor and uses thereof ATG7, SQSTM1, BECN1 MAP1LC3B 15/4885HTR2C 3931/4885MEN1 3447/4885
US-20200190066-A1 COMPOUND USED AS AUTOPHAGY REGULATOR, AND PREPARATION METHOD THEREFOR AND USES THEREOF ATG7, SQSTM1, BECN1 MAP1LC3B 15/4885HTR2C 3931/4885MEN1 3447/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.